Braun Stacey Associates’s Xylem XYL Stock Holding History

Braun Stacey Associates’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-57,735	Closed	-$4.44M	–	132
2018 Q1	$4.44M	Buy	57,735 +14,480	+33%	+$1.07M	0.31%	99
2017 Q4	$2.95M	Buy	43,255 +9,580	+28%	+$636K	0.2%	107
2017 Q3	$2.11M	Buy	33,675 +10,015	+42%	+$599K	0.14%	107
2017 Q2	$1.31M	Sell	23,660 -80,485	-77%	-$4.19M	0.09%	115
2017 Q1	$5.23M	Sell	104,145 -167,125	-62%	-$8.15M	0.33%	97
2016 Q4	$13.4M	Buy	+271,270	New	+$13.8M	0.88%	54

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Braun Stacey Associates's XYL Position: Q2 2018 in Review

Braun Stacey Associates sold out of Xylem (XYL) in Q2 2018, closing a stake of 57,735 shares — an estimated $4.44M sold.

Braun Stacey Associates first reported a position in XYL in Q4 2016 and held it in 6 quarters. The position peaked at $13.4M in Q4 2016. 644 funds tracked by Wall St. Rank hold XYL as of Q2 2018.

Braun Stacey Associates reported no remaining Xylem position as of Q2 2018 after selling out during the quarter.
Braun Stacey Associates sold 57,735 Xylem shares in Q2 2018, an estimated $4.44M.
Braun Stacey Associates first reported a position in Xylem in Q4 2016 and held it in 6 quarters.
Braun Stacey Associates's Xylem position peaked at $13.4M in Q4 2016.
644 funds tracked by Wall St. Rank held Xylem as of Q2 2018.

Based on Braun Stacey Associates's 13F filing for Q2 2018, filed 1 Aug 2018.